{
    "Trade/Device Name(s)": [
        "Randox Benzodiazepine Calibrator Set",
        "Randox Benzodiazepine Controls Level 1 and 2"
    ],
    "Submitter Information": "Randox Laboratories Limited",
    "510(k) Number": "K132090",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051088"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "August 8, 2013",
    "Summary Letter Received Date": "July 15, 2013",
    "Submission Date": "July 3, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Clinical toxicology calibrator"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Oxazepam"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "RX Daytona",
        "RX Imola"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Randox Benzodiazepine Calibrator Set and Controls for calibration and quality control of benzodiazepine assays on RX series analysers using human urine specimens.",
    "Indications for Use Summary": "Developed for calibration and quality control/validation of benzodiazepine assays (using Oxazepam) on RX series analysers in human urine; intended for prescription use only.",
    "fda_folder": "Toxicology"
}